American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$376M |
| 2 |
Intuitive Surgical
ISRG
|
$322M |
| 3 |
AT&T
T
|
$293M |
| 4 |
Pfizer
PFE
|
$259M |
| 5 |
Bank of America
BAC
|
$180M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$253M |
| 2 |
PG&E
PCG
|
$237M |
| 3 |
CVS Health
CVS
|
$229M |
| 4 |
Newell Brands
NWL
|
$217M |
| 5 |
TWX
Time Warner Inc
TWX
|
$208M |
Sector Composition
| 1 | Financials | 16.03% |
| 2 | Healthcare | 13.43% |
| 3 | Technology | 13.04% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
MetLife
MET
$54.1B
| $335M | 0.33% | 6,625,997 +619,487 | +10% | +$31.3M |
|
77
Regeneron Pharmaceuticals
REGN
$61.5B
| $330M | 0.33% | 877,587 -39,967 | -4% | -$15M |
|
78
EQT Corp
EQT
$32.4B
| $329M | 0.33% | 5,785,927 -857 | -0% | -$48.8K |
|
79
Zions Bancorporation
ZION
$8.56B
| $320M | 0.32% | 6,301,387 +136,198 | +2% | +$6.92M |
|
80
Texas Instruments
TXN
$184B
| $320M | 0.32% | 3,062,438 -126,753 | -4% | -$13.2M |
|
81
Biogen
BIIB
$19.4B
| $319M | 0.32% | 1,001,387 +95,432 | +11% | +$30.4M |
|
82
Keysight
KEYS
$28.1B
| $316M | 0.31% | 7,596,674 +2,613,683 | +52% | +$109M |
|
83
Monster Beverage
MNST
$60.9B
| $303M | 0.3% | 4,794,735 -250,139 | -5% | -$15.8M |
|
84
Electronic Arts
EA
$43B
| $303M | 0.3% | 2,883,283 +171,179 | +6% | +$18M |
|
|
WP
85
DELISTED
Worldpay, Inc.
WP
| $302M | 0.3% | 4,099,986 +1,495,258 | +57% | +$110M |
|
86
Halliburton
HAL
$19.4B
| $301M | 0.3% | 6,153,365 +1,684,961 | +38% | +$82.3M |
|
87
Starbucks
SBUX
$100B
| $299M | 0.3% | 5,197,739 +445,784 | +9% | +$25.6M |
|
88
Amgen
AMGN
$155B
| $297M | 0.3% | 1,707,514 +429,748 | +34% | +$74.7M |
|
89
Roper Technologies
ROP
$56.6B
| $295M | 0.29% | 1,139,955 -152,840 | -12% | -$39.6M |
|
90
Ametek
AME
$42.7B
| $295M | 0.29% | 4,067,798 +1,214,153 | +43% | +$88M |
|
|
91
Bank of America Series L
BAC.PRL
$3.84B
| $294M | 0.29% | 223,045 +16,529 | +8% | +$21.8M |
|
|
WRK
92
DELISTED
WestRock Company
WRK
| $293M | 0.29% | 4,631,286 +1,138,884 | +33% | +$72M |
|
93
DXC Technology
DXC
$2.59B
| $292M | 0.29% | 3,075,375 +198,486 | +7% | +$18.8M |
|
94
Tapestry
TPR
$21.2B
| $287M | 0.29% | 6,496,813 +341,095 | +6% | +$15.1M |
|
95
Intercontinental Exchange
ICE
$101B
| $284M | 0.28% | 4,025,068 -131,054 | -3% | -$9.25M |
|
96
Royal Caribbean
RCL
$98.7B
| $283M | 0.28% | 2,375,875 +1,002,700 | +73% | +$120M |
|
97
GE Aerospace
GE
$292B
| $280M | 0.28% | 16,026,525 +642,734 | +4% | +$11.2M |
|
98
Fortune Brands Innovations
FBIN
$7.02B
| $277M | 0.28% | 4,040,260 -192,093 | -5% | -$13.1M |
|
99
Imperial Oil
IMO
$46.2B
| $275M | 0.27% | 8,826,969 -1,935,724 | -18% | -$60.4M |
|
|
INFO
100
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $273M | 0.27% | 6,040,310 +769,108 | +15% | +$34.7M |
|